Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced homogeneous phase process for DHEA acetate production improves yield to 85% and eliminates carcinogenic solvents, offering reliable pharmaceutical intermediate supply.
Patent CN114790151A reveals a cost-effective composite catalytic route for methyl 2-cyano-2-valproate, offering significant supply chain advantages for valproamide manufacturing.
This patent details a refined milrinone production method ensuring high purity and reduced pollution. It offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing partners.
Patent CN116143652A reveals a cost-effective route for afoxolaner intermediates. Achieve high purity and scalable production for veterinary pharmaceuticals with optimized chemistry.
Discover a green, metal-free method for synthesizing 2-substituted 3-methylindole derivatives using g-C3N4 photocatalysis, offering cost reduction and high purity for pharmaceutical manufacturing.
Advanced synthetic route for 6'-N-ethyl gentamicin C1a impurity standard. Enhances etimicin sulfate quality control with high-purity manufacturing capabilities.
Patent CN107365264A reveals a novel NIS-oxidized route for sulfonamide synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel ultrasonic-assisted method for gemfibrozil intermediate ensures high purity and yield. Reliable supply chain partner for pharmaceutical manufacturing cost reduction and scalability.
Patent CN108046976A reveals a modular four-step route for high-purity trisubstituted benzene. This method ensures supply chain reliability and cost efficiency for electronic chemical manufacturing.
Patent CN103665026A details a mild, one-step conversion of aromatic amines to aryl tin compounds using Lewis acids, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106831603A reveals a visible-light promoted, transition-metal-free synthesis of perfluoroalkylpyrimidines, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN113214094A details a novel 11-step voglibose synthesis from glucose, offering significant cost reduction in API manufacturing through mild conditions and high yields.
Discover the novel 5-step synthesis for Roflumilast intermediate I. Enhanced yield, no chromatography, and scalable industrial production for global supply chains.
Patent CN117448309A reveals biocatalytic synthesis for high-purity pregabalin intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN103201035B enables halogen-free oxidative carbonylation. Delivers high purity carbamates with reduced corrosion and substantial cost savings for supply chains.
Patent CN111778229B reveals high-efficiency hydrolase mutants for >99% ee production. Ideal for reliable pharma intermediate supply chains.
Novel Ti-Ni catalytic method for allyl alcohol compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111270260B reveals a green Rh-catalyzed C-H activation route using electricity, offering cost-effective API intermediate manufacturing without external oxidants.
Patent CN109553538B reveals continuous fixed-bed catalysis for high-purity 1 2-cyclohexanediamine. This breakthrough ensures supply chain stability and cost efficiency.
Patent CN106631740A details a novel NHC-catalyzed route for cyclopent-2-enone-4-ols. Offers high dr, mild conditions, and supply chain advantages for pharma intermediates.